In multiple myeloma, acute lymphoblastic leukemia, and prostate cancer, WHSC1 has been found to be either overexpressed or hyperactivated, resulting in increased methylation of H3K36 on promoters of oncogenes (24, 25). Here, NSD2 is linked to Familial prostate cancer.